会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • METHODS AND COMPOSITIONS FOR TREATING ALCOHOL USE DISORDERS
    • 治疗酒精使用障碍的方法和组合物
    • WO2017083795A1
    • 2017-05-18
    • PCT/US2016/061729
    • 2016-11-12
    • SANNA, Pietro, Paolo
    • SANNA, Pietro, Paolo
    • A61K31/194C07J63/00A61P25/32
    • A61K31/585A61K31/22A61K31/4965A61K31/56A61K31/573A61K31/58A61K38/39A61K45/06C07J63/008A61K2300/00
    • Disclosed are methods and compositions for treating alcohol dependence by administration to a patient of an inhibitor of 11β-hydroxysteroid dehydrogenases (11β-HSD) to modulate glucocorticoid effects. One such compound is the 11β-HSD inhibitor carbenoxolone (18β-glycyrrhetinic acid 3β-O-hemisuccinate), which has been extensively employed in the clinic for the treatment of gastritis and peptic ulcer. Carbenoxolone is active on both 11β-HSD1 and 2 isoforms. Here, carbenoxolone is surprisingly shown to reduce both baseline and excessive drinking in rats and mice. The carbenoxolone diastereomer 18α-glycyrrhetinic acid 3β-O-hemisuccinate (αCBX), which the applicants discovered to be selective for 11β-HSD2, was also effective in reducing alcohol drinking in mice. Thus, 11β-HSD inhibitors are a new class of candidate alcohol abuse medications and existing 11β-HSD inhibitor drugs may be re-purposed for alcohol abuse treatment.
    • 公开了通过向患者施用11β-羟基类固醇脱氢酶(11β-HSD)抑制剂以调节糖皮质激素效应来治疗酒精依赖性的方法和组合物。 一种这样的化合物是11β-HSD抑制剂生胃酮(18β-甘草次酸3β-O-半琥珀酸盐),其在临床上广泛用于治疗胃炎和消化性溃疡。 Carbenoxolone对11β-HSD1和2同种型均有活性。 在这里,令人惊讶地证明甘珀酸减少大鼠和小鼠的基线和过量饮酒。 本申请人发现对于11β-HSD2具有选择性的生菌酮非对映异构体18α-甘草次酸3β-O-半琥珀酸盐(αCBX)在减少小鼠饮酒中也是有效的。 因此,11β-HSD抑制剂是一类新的候选酒精滥用药物,并且现有的11β-HSD抑制剂药物可能被重新用于酗酒治疗。